Krsnaa Diagnostics plans to acquire a 24% stake in Apulki Healthcare, securing exclusive rights to provide diagnostic services at Apulki’s oncology and cardiology hospitals. This partnership will ensure Krsnaa’s leadership in these segments for over 30 years, offering advanced diagnostic technologies across Apulki’s planned network of hospitals in India.
Related Posts
Stock market today: BSE Sensex opens in green; Nifty50 near lifetime high
Stock market today: Indian equity benchmark indices, BSE Sensex and Nifty50, opened in green on Wednesday. While BSE Sensex was above 81,800, Nifty50 was near […]
China sanctions 13 US military firms over Taiwan arms sales
China imposed sanctions on 13 US military companies and six executives following US arms sales to Taiwan and President Lai Ching-te’s US transit. Beijing views […]
Stock market today: BSE Sensex rises over 200 points; Nifty50 near 24,300
Stock market today: Indian equity benchmark indices, BSE Sensex and Nifty50, opened in green on Tuesday. While BSE Sensex crossed the 80,300 mark, Nifty50 was […]